Dr. Douglas Fowler's lab at the University of Washington focuses on understanding why cells behave differently under various conditions. They explore how genetic differences, along with environmental factors, contribute to these variations in cell behavior. Their research has led to the development of innovative techniques for assessing the impact of genetic variants on cellular functions, which have broad implications for personalized medicine and disease treatment.

Dr. Kevin Michael King's research lab at the University of Washington focuses on understanding how people use alcohol to manage their emotions. They study both positive and negative feelings to see how these influence drinking behaviors. By using advanced data collection methods, they aim to provide insights that could lead to better treatments for alcohol use disorders.

Wendy E Thomas's lab at the University of Washington studies how certain bacteria, specifically oral streptococci, contribute to a serious heart infection called infective endocarditis. Her research focuses on how these bacteria interact with sugars on human cells, which influences their ability to cause infection. By understanding these interactions better, the lab aims to find new strategies for preventing and treating this life-threatening condition.

Daniel T. Chiu's lab at the University of Washington focuses on developing innovative technologies to study gene expression in tissues and fetal health. They work on advanced imaging methods for analyzing tissues and biomarkers found in pregnant women, providing critical insights into conditions like neonatal abstinence syndrome. Their research combines chemistry and molecular biology techniques to enhance our understanding of complex biological systems.

Dr. Elia D. Tait Wojno's lab at the University of Washington focuses on understanding how the body responds to gut parasites and allergens, especially in relation to inflammation. The research emphasizes the role of a specific lipid and its receptor, which are crucial in managing inflammation in the intestines. By studying how these factors interact, the lab aims to uncover new ways to treat conditions related to inflammation in the gut.

Libin Xu's lab at the University of Washington focuses on understanding how exposure to benzalkonium chloride (BAC), a common disinfectant, impacts the gut microbiome and liver metabolism. This research is particularly relevant given the increased use of disinfectants during the COVID-19 pandemic. The lab employs animal models and human samples to investigate how BAC alters microbial diversity and metabolic processes, aiming to shed light on the health implications of these environmental exposures.

Dr. Steve I. Perlmutter's laboratory focuses on improving recovery from spinal cord injuries using a novel neuroprosthetic therapy. The lab explores the use of targeted spinal stimulation to enhance movement in individuals who have suffered from cervical spinal cord injuries. By investigating the body's natural ability to adapt and recover neural functions, the lab aims to develop more effective rehabilitation methods and prepare for future clinical applications.

Dr. Azadeh Yazdan Shahmorad's lab focuses on harnessing the brain's natural ability to change and reorganize itself, known as neuroplasticity. Through advanced engineering tools and techniques, the lab investigates how targeted stimulation of the sensory and motor areas of the brain can aid recovery after injuries, like strokes. Their work explores how precise control of brain activity can strengthen connections between neurons, promoting healing and rehabilitation.

Dr. Robert S Miyaoka's lab at the University of Washington focuses on improving cancer treatment for neuroendocrine tumor patients through precision medicine. They are developing an innovative at-home device that allows patients to monitor their radiation exposure safely and conveniently, enabling personalized therapies based on individual measurements. The lab aims to make cancer treatments more effective while reducing side effects and the need for frequent hospital visits.

Dr. Charles L. Asbury's lab at the University of Washington studies how the mitotic spindle, a complex molecular machine, separates chromosomes during cell division. By using purified components and advanced biophysical tools, they investigate the mechanics of the spindle and kinetochores, uncovering how these structures ensure accurate chromosome segregation. Their research aims to deepen our understanding of cellular processes, with implications for developing new cancer treatments.

Dr. Christopher Dirk Keene's lab focuses on understanding the complex relationship between traumatic brain injuries and the progression of Alzheimer's disease and related dementias. The lab aims to establish a comprehensive resource that combines brain imaging, neuropathology, and extensive clinical data to improve diagnostics and therapeutic strategies for affected individuals. The research not only emphasizes scientific insights but also prioritizes diversity and inclusion within the research community.

Dr. Douglas F. Zatzick's lab at the University of Washington focuses on improving mental health outcomes for trauma survivors. The lab conducts research to develop and test effective interventions for post-traumatic stress disorder (PTSD) and related conditions among individuals who have experienced severe injuries. By employing pragmatic trials, the lab aims to influence trauma care policies and enhance mental health services across the United States.

Dr. Alison F Feder's lab focuses on understanding the evolution of solid tumors and their progression to metastasis. By developing innovative methods that combine genetics and computational modeling, the lab aims to reconstruct the historical growth of tumors and predict their future behavior. This research is crucial for creating effective diagnostic tools and improving cancer treatment by providing insights into tumor dynamics and the identification of critical mutations.

Professor Rachel Klevit's lab at the University of Washington studies how proteins are modified by a process called ubiquitylation, which affects their function and stability in cells. This research is important for understanding various human diseases, including cancer, as the modification of proteins can influence cellular processes such as growth and stress responses. The lab focuses on the proteins involved in this modification process and aims to uncover new therapeutic targets to address these diseases.

Dr. James D. Bryers' lab focuses on innovative vaccine delivery systems using injectable hydrogels. They aim to develop self-replicating mRNA vaccines specifically targeting Staphylococcus aureus, a dangerous bacteria responsible for severe infections. By creating biodegradable hydrogel depots, the lab seeks to improve vaccine efficacy and safety through a single injection method rather than repeated doses.

Dr. Cecilia Giachelli's lab at the University of Washington is focused on understanding how and why calcium builds up in blood vessels and heart valves, a process known as vascular calcification. This condition can lead to serious heart issues, especially in older adults and those with diabetes or kidney disease. The lab investigates the biological processes and genetic factors involved in this calcification to identify potential treatments and biomarkers that can improve cardiovascular health and prevent complications.

Dr. Jeffrey Riffell's lab at the University of Washington studies how mosquitoes use their vision and sense of smell to find hosts and food sources. They investigate the connection between color vision and odor cues in mosquitoes, aiming to understand how these insects make decisions about where to land and feed. Through advanced genetic techniques and behavioral experiments, they hope to enhance mosquito control strategies and reduce the transmission of mosquito-borne diseases.

Dr. Jonathan R Weinstein's lab at the University of Washington focuses on understanding the role of microglia, which are the brain's immune cells, in chronic cerebrovascular diseases and cognitive impairment. By using advanced mouse models and imaging techniques, the lab investigates how microglial signaling drives white matter damage associated with conditions like dementia. The ultimate goal is to identify new diagnostics and treatment strategies that could improve outcomes for patients suffering from vascular cognitive impairment.

Dr. Jessica Elaine Young's research lab focuses on understanding the mechanisms behind Alzheimer's Disease (AD), particularly the roles of genetics and cell type-specific functions in disease progression. Her lab investigates endo-lysosomal dysfunction in human neural cells and how sex-linked genetic factors influence the onset and progression of AD. By utilizing human-induced pluripotent stem cells (hiPSCs) and patient-derived tissues, the lab aims to identify potential therapeutic targets for AD and better understand the differential effects of genetics on male and female patients.

Dr. Larry S. Zweifel's lab at the University of Washington focuses on how our emotions, especially positive and negative feelings, interact in the brain to affect learning and memory. By studying the central amygdala, a brain area involved in processing emotions, the lab aims to understand how positive stimuli can alter responses to fear and anxiety. This research has important implications for improving therapies for anxiety disorders, making them more effective in treating patients.